OptimizeRx Corporation OPRX 深 沪
已收盘 07-02 16:00:00 美东时间
6.19
+0.110
+1.81%
华盛通- 最 高6.50
- 今 开6.14
- 成交量 51.96万股
- 最 低 6.04
- 昨 收 6.08
- 总市值 1.16亿
- 52周最高 22.25
- 市盈率 静 22.92
- 换手率 2.77%
- 52周最低 4.54
- 委 比 11.36%
- 总股本 1876.51万
- 历史最高 99.178
- 量 比 0.67
- 振 幅 7.57%
- 历史最低 3.78
- 每 手 1
- 风险率 5.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多OptimizeRx Rolls Out CopayCue To Provide Enhanced Brand Savings For Physicians
OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at the most important decision points, today announced the launch of CopayCue™, designed to make brand ...
06-30 19:38
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
OptimizeRx Corp launched CopayCue™, a next-generation technology that integrates brand savings offers into the e-prescribing workflow using real-time HCP prescribing intent data. Designed to enhance medication affordability and access, CopayCue™ aims to increase prescription lift and improve patient adherence by delivering savings information directly to physicians and pharmacies. The solution addresses the significant issue of medication non-adh...
06-30 11:30
OptimizeRx Shareholders Expand Equity Plan, Maintain Oversight
OptimizeRx ( ($OPRX) ) has shared an announcement. At its June 9, 2026 annual m...
06-13 04:43
OptimizeRx's Electronic Health Record Network Integrated By DeepIntent
OptimizeRx Corp. (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare providers (HCPs) and patients at the most important decision points, today
05-21 19:31
OptimizeRx partners with DeepIntent to integrate authenticated EHR network into DSP platform
OptimizeRx partners with DeepIntent to integrate authenticated EHR network into DSP platform OptimizeRx entered a partnership with healthcare advertising platform DeepIntent to integrate its authenticated electronic health record network into DeepIntent’s demand-side platform. The tie-up gives life
05-21 19:31
美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
Stifel Maintains Buy on OptimizeRx, Lowers Price Target to $14
Stifel analyst David Grossman maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $17 to $14.
05-13 21:45
美股异动丨OptimizeRx盘前跌4% Q1营收降10%但盈利翻倍 下调全年指引
格隆汇5月13日｜专注于医疗健康领域的数字技术公司OptimizeRx(OPRX.US)盘前跌4%报6美元。消息上，OptimizeRx于5月12日盘后公布了...
05-13 17:16
OptimizeRx Reports Q1 2026 Results: Full Earnings Call Transcript
OptimizeRx (NASDAQ:OPRX) released first-quarter financial results and hosted an...
05-13 05:08
OptimizeRx Secures New Credit Facility to Boost Flexibility
OptimizeRx ( ($OPRX) ) just unveiled an announcement. On May 7, 2026, OptimizeR...
05-13 05:01
